《大空头》原型Q2完美踏准节奏:“抄底”美股,空翻多押注中概股,与巴菲特“默契”看涨联合健康(UNH.US)

Core Insights - Michael Burry's Scion Asset Management reported a significant increase in its U.S. stock holdings, with a total market value of approximately $580 million for Q2 2025, up 191.5% from $199 million in the previous quarter [1] - The fund added 14 new stocks, reduced its holdings in one stock, and completely exited six stocks, with the top ten holdings accounting for 92.37% of the total portfolio value [1] - Notably, Scion's bullish position on UnitedHealth Group (UNH) aligns with Berkshire Hathaway's recent investment strategy, indicating a shared optimism about the healthcare sector's recovery [1][2] Holdings Summary - The top holding in Scion's portfolio is UnitedHealth Group, with a market value of $190 million, representing 18.88% of the portfolio [3][6] - Other significant holdings include Regeneron Pharmaceuticals (REGN) at $105 million (18.16%), Lululemon Athletica (LULU) at $95 million (16.43%), and Meta Platforms (META) at $73.8 million (12.76%) [3][6] - The fund's top five purchases in Q2 were UnitedHealth Group, Regeneron, Lululemon, Meta, and Estee Lauder [4][6] Selling Activity - The top five sell positions included put options for Nvidia (NVDA), Alibaba (BABA), Pinduoduo (PDD), JD.com (JD), and Trip.com (TCOM) [5][6] - The fund significantly reduced its exposure to Chinese tech stocks, reflecting a shift in investment strategy compared to the previous quarter [7][9] Market Context - UnitedHealth's stock is currently trading near a five-year low, down 57.4% from its 52-week high, which may present a buying opportunity as Burry seeks value in the company [2] - The overall market sentiment has shifted positively, with the S&P 500 and Nasdaq indices achieving double-digit gains in Q2, indicating a recovery in investor confidence [7][9]